Allogene Therapeutics (ALLO) Return on Sales (2021 - 2024)
Allogene Therapeutics (ALLO) reported Return on Sales of 184.5% for Q4 2024, down 14981.0% on a YoY basis from N/an in Q1 2024, and down 88.35% sequentially from 97.95% in Q3 2024.
Allogene Therapeutics (ALLO) Return on Sales (2021 - 2024) Analysis & Trends
Allogene Therapeutics (ALLO) has 4 years of Return on Sales data on file, last reported at 184.5% in Q4 2024.
- For the quarter ending Q4 2024, Return on Sales fell 14981.0% year-over-year to 184.5%; the trailing twelve-month figure through Dec 2024 stood at 184.5% (down 14477.0% YoY), and the FY2024 full-year result was 117.09%, down 8264.0% from the prior year.
- Return on Sales slipped to 184.5% in Q4 2024, from 97.95% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2021 to a low of 184.5% in Q4 2024.
- A 4-year average of 48.23% and a median of 35.0% in 2024 frame the typical range for Return on Sales.
- Across the five-year window, Return on Sales surged 4170 bps in 2023 and plunged 14981 bps in 2024, its largest moves.
- Tracing ALLO's Return on Sales over 4 years: stood at 0.0% in 2021, then slumped by 2000000000 bps to 38.67% in 2022, then grew by 10 bps to 34.69% in 2023, then plunged by 432 bps to 184.5% in 2024.
- Business Quant data shows ALLO's Return on Sales at 184.5% in Q4 2024, 97.95% in Q3 2024, and 66.78% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Allogene Therapeutics | 437.33 Mn | 437.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -184.50% |
| Sep 30, 2024 | -97.95% |
| Jun 30, 2024 | -66.78% |
| Mar 31, 2024 | -35.31% |
| Dec 31, 2023 | -34.69% |
| Sep 30, 2023 | -41.61% |
| Jun 30, 2023 | -51.37% |
| Mar 31, 2023 | -33.34% |
| Dec 31, 2022 | -38.67% |
| Sep 30, 2022 | -83.31% |
| Jun 30, 2022 | -17.05% |
| Mar 31, 2022 | -20.90% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -32.73% |
| Jun 30, 2021 | -33.39% |
| Mar 31, 2021 | -0.01% |